Preclinical Testing of FDA-Approved Drugs Repurposed for Potential Novel Tocolytic Use.

被引:0
|
作者
Siricilla, Shajila [1 ]
Hansen, Christopher J. [2 ]
Staub, Jeremy D. [1 ]
Walker, Jordan [2 ]
Brown, Alexus J. [1 ]
Benjamin, John [1 ]
Herington, Jennifer L. [1 ,2 ]
机构
[1] Vanderbilt Univ, Med Ctr, Nashville, TN USA
[2] Vanderbilt Univ, Nashville, TN USA
关键词
D O I
暂无
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
T-018
引用
收藏
页码:119A / 120A
页数:2
相关论文
共 50 条
  • [21] Repurposing of FDA-approved drugs as novel radiosensitisers in hypoxic prostate cancer
    Bibby, B.
    Thiruthaneeswaran, N.
    Yang, L.
    McArt, D.
    O'Reilly, P.
    Roberts, D.
    Choudhury, A.
    West, C.
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S195 - S195
  • [22] A review on synthesis of FDA-approved antipsychotic drugs
    Rani, Anjali
    Aslam, Mohd
    Pandey, Garima
    Pant, Bhaskara Nand
    TETRAHEDRON, 2023, 138
  • [23] An analysis of FDA-approved drugs for pain and anesthesia
    Kinch, Michael S.
    DRUG DISCOVERY TODAY, 2015, 20 (01) : 3 - 6
  • [24] An analysis of FDA-approved drugs for metabolic diseases
    Kinch, Michael S.
    Umlauf, Sheila
    Plummer, Mark
    DRUG DISCOVERY TODAY, 2015, 20 (06) : 648 - 651
  • [26] Re-Purposing FDA-Approved Drugs for Opioid Use Disorder
    Patel, Krishna
    Waldron, David
    Graziane, Nicholas
    SUBSTANCE USE & MISUSE, 2023, 58 (13) : 1751 - 1760
  • [28] An analysis of FDA-approved drugs for psychiatric disorders
    Kinch, Michael S.
    Patridge, Eric
    DRUG DISCOVERY TODAY, 2015, 20 (03) : 292 - 295
  • [30] FDA-approved drugs in 2022: A brief outline
    Al-Madhagi, Haitham Ahmed
    SAUDI PHARMACEUTICAL JOURNAL, 2023, 31 (03) : 401 - 409